Mark C Jasek

Mark C Jasek, PhD has over twenty years of experience in ophthalmology, with additional expertise in oncology and neurology. Currently serving as the Chief Operating Officer at SightStream Biotherapeutics, Mark has held various leadership roles in pharmaceutical companies such as Eyevance Pharmaceuticals, Sun Pharma, and Alcon, a division of Novartis. Mark's extensive background includes managing clinical development programs, medical affairs initiatives, product development, and global scientific market affairs. With a strong educational foundation, including a PhD in Pharmacology and Toxicology, Mark brings a wealth of knowledge and expertise to the industry.